Atossa Therapeutics Inc [NASDAQ: ATOS] stock went on a downward path that fall over -12.34% on Wednesday, amounting to a one-week price decrease of less than -22.86%. Over the last 12 months, ATOS stock rose by 82.43%. The one-year Atossa Therapeutics Inc stock forecast points
Atossa Therapeutics Inc [NASDAQ: ATOS] jumped around 0.09 points on Tuesday, while shares priced at $1.84 at the close of the session, up 5.14%. The company report on April 9, 2024 at 11:59 AM that Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2
Atossa Therapeutics Inc [NASDAQ: ATOS] gained 3.70% or 0.07 points to close at $2.10 with a heavy trading volume of 3984546 shares. The company report on April 1, 2024 at 4:00 PM that Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update. Fully
Atossa Therapeutics Inc [NASDAQ: ATOS] gained 20.16% on the last trading session, reaching $1.55 price per share at the time. The company report on March 19, 2024 at 8:30 AM that Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved “Expanded Access” Program for a
© 2024, Powered by Smart TechOne
